...to biosimilars competing with the originator products. The prime example is the ongoing litigation between Pfizer...

...CDC said the second dose of COVID-19 vaccines from Moderna Inc. (NASDAQ:MRNA) and partners BioNTech SE (NASDAQ:BNTX) and Pfizer...
...weeks after the first dose. The prior recommendation had been three weeks for Comirnaty from Pfizer...
...mRNA vaccines are not interchangeable with each other or with other COVID-19 vaccines. Separately, BioNTech and Pfizer...

...unit of Johnson & Johnson (NYSE:JNJ), Moderna Inc. (NASDAQ:MRNA), Novavax Inc. (NASDAQ:NVAX) and Sanofi (Euronext:SAN; NASDAQ:SNY).A sixth company, Pfizer...
...statements by Pfizer Chairman and CEO Albert Bourla after its vaccine was authorized by FDA, Pfizer...
...risk was with Pfizer and all of the technical approach to the vaccine was with Pfizer...

...majority owned by GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), Pfizer...

...molecules, versus biologics or gene therapies."SciNeuro’s management team includes CMO Qiuqing Ang, a veteran of GSK, Pfizer...
...Pharma Inc.; SVP & Head of Translational Science Danny Chen, formerly an executive director at Pfizer...

...the two mRNA vaccines —from BioNTech SE (NASDAQ:BNTX) and Pfizer...
...N501Y substitution.The report comes two weeks after Pfizer...
...epitopes. Sandi Wong mRNA-1273 Comirnaty (PF-07302048, BNT162, BNT162b2) etesevimab (LY-CoV016, JS016) BioNTech SE Pfizer...

...in the towel. Prior failures in the class included Phase III disappointments for torcetrapib from Pfizer...

...after neoadjuvant treatment with J&J’s Erleada apalutamide, Xtandi enzalutamide from Astellas Pharma Inc. (Tokyo:4503) and Pfizer...

...isolated from across the globe and assembled by pharmas including Merck & Co. Inc. (NYSE:MRK), Pfizer...

...of the vaccines that have had efficacy readouts since the mRNA vaccines from Moderna Inc. (NASDAQ:MRNA) and partners Pfizer...
...JNJ-78436735 from Johnson & Johnson (NYSE:JNJ), for which data are expected this month. Selina Koch Moderna Inc. Sinovac Biotech Ltd. Pfizer...